medlr news Eli Lilly Introduces Mounjaro in India for Obesity and Type 2 Diabetes Eli Lilly introduces Mounjaro (tirzepatide) in India, a dual GIP and GLP-1 receptor agonist designed for chronic weight management and type 2 diabetes.
News Bariatric Surgery Outperforms Lifestyle Changes in Diabetes Remission A groundbreaking study challenges the usual approach to type 2 diabetes in obese individuals. Researchers at the University of Pittsburgh found bariatric surgery to be significantly more effective than lifestyle changes in achieving diabetes remission.
News Rising Cases of Chronic Kidney Disease Pose Urgent Concern: Are We Prepared? Chronic kidney disease (CKD) poses a significant threat in India, affecting an estimated 17% of the population. This alarming prevalence stems from various factors, including the rising tide of diabetes and hypertension
